Related Experiment Video
Updated: Feb 8, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration
Yanling Chen1, Di Wu2, Chun Yang2
1Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215003, China; Department of Hematology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi, Jiangsu, 214023, China.
Abstract:
Neuroblastoma (NB) is a prevalent pediatric tumor, accounting for over 15% of cancer-related fatalities in children. Super-enhancers (SEs), as pivotal cis-regulatory elements known for driving oncogene expression across various tumors, may serve as an innovative strategy for deciphering NB pathogenesis. Here, we meticulously analyzed epigenomic and transcriptomic data to delineate the distinct SE landscape in NB. Our study identified a NB-specific and NB-common SE at the MAB21L2 locus. Functional analyses further underlined MAB21L2's oncogenic role in NB, linking its high expression to poor patient outcomes. MAB21L2 knockdown strikingly inhibited the growth of NB tumor cells in vitro and reduced their proliferation in vivo. Notably, through RNA-seq analysis and experimental verification, we demonstrated that MAB21L2 substantially enhanced the migratory capacity of NB cells. Collectively, these findings underscore the indispensable role of the super-enhancer-MAB21L2 axis in the pathogenesis of NB and provide mechanistic insights into NB progression.
Insights
Super-enhancers drive neuroblastoma (NB) growth by regulating MAB21L2. Targeting this super-enhancer-MAB21L2 axis offers a new strategy for treating pediatric NB tumors.
Area of Science:
- Oncology
- Genetics
- Epigenetics
Background:
- Neuroblastoma (NB) is a major cause of childhood cancer mortality.
- Super-enhancers (SEs) are crucial for oncogene expression in tumors.
- Understanding SEs in NB is key to novel therapeutic strategies.
Purpose of the Study:
- To identify and characterize the super-enhancer landscape in neuroblastoma.
- To investigate the role of MAB21L2, regulated by SEs, in NB pathogenesis.
- To explore the therapeutic potential of targeting the SE-MAB21L2 axis.
Main Methods:
- Analysis of epigenomic and transcriptomic data in NB.
- Identification of NB-specific and NB-common SEs.
- Functional assays including gene knockdown, in vitro/in vivo studies, and RNA-seq.
Main Results:
- A specific SE regulating MAB21L2 was identified in NB.
- High MAB21L2 expression correlates with poor NB patient outcomes.
- MAB21L2 knockdown inhibited NB cell growth, proliferation, and migration.
Conclusions:
- The super-enhancer-MAB21L2 axis is critical for neuroblastoma pathogenesis.
- MAB21L2 promotes NB cell growth, migration, and poor prognosis.
- Targeting this axis presents a promising therapeutic avenue for NB.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:48Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds
Published on: July 9, 2021
Related Concept Videos
Migration
Super-resolution Fluorescence Microscopy
Self-Evaluation: Self-Enhancement and Self-Verification
Cell Migration
Cell Migration
Population Growth